ArticleEClinicalMedicine2022

Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial.

Hideto Yamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.